Clinical Trials Logo

Filter by:
NCT ID: NCT05545046 Completed - Clinical trials for Hepatocellular Carcinoma

Predictive Model for Pain After TACE

Start date: September 1, 2019
Phase:
Study type: Observational [Patient Registry]

The main aim of this study was to analyze the risk factors that helped to predict the pain after transarterial chemoembolization (TACE).This was a prospective observational study enrolled all hepatocellular carcinoma (HCC) patients undergoing TACE in our hospital. Pain score at rest was assessed after TACE by the patients themselves using a Visual Analogue Scale (VAS). Independent variables such as age, gender, tumor location, tumor size and number, drug delivery method and presence of portal vein tumor thrombosis (PVTT) were recorded and analyzed.

NCT ID: NCT05544812 Recruiting - Colorectal Cancer Clinical Trials

A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer

Start date: May 1, 2022
Phase:
Study type: Observational

The purpose of this study is to acssess the efficacy and the safety of Sintilimab plus bevacizumab/cetuximab plus XELOX regimen for conversion therapy in patients with advanced colorectal cancer

NCT ID: NCT05544591 Completed - Dermatitis, Atopic Clinical Trials

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Start date: October 26, 2022
Phase: Phase 2
Study type: Interventional

The primary objective of the study was to evaluate the efficacy and safety of 611 in chinese adults with moderate to severe atopic dermatitis.

NCT ID: NCT05544253 Recruiting - Clinical trials for Hepatocellular Carcinoma

Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Start date: October 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Hepatocellular carcinoma (HCC) is featured by the spontaneously rupture when suffering severe cirrhosis and intratumoral overpressure. It is a fatal complication with an acute mortality. Importantly, it is served as an independent risk factor for peritoneal metastasis (PM) of HCC with poor prognosis. The systematic agents effective to extrahepatic lesions confers modest efficacy towards PM. HIPEC, as a novel strategy, has been proved by overwhelming studies that it is effective to peritoneal malignant tumors. However, there is absence of prospective study of HIPEC efficacy towards HCC.

NCT ID: NCT05544149 Recruiting - Clinical trials for SCLC,Extensive Stage

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

To Evaluate the Safety and Efficacy of Thoracic Radiotherapy for?ES-SCLC After First Line Treatment with Immune Checkpoint Inhibitors.

NCT ID: NCT05544123 Recruiting - Breast Cancer Clinical Trials

The Treatment Situation of Chinese County Population With Breast Cancer

Start date: September 29, 2022
Phase:
Study type: Observational

The study is a multi-center, non-interventional, prospective observational study which enrols 2500 breast cancer patients from China county area. The purpose of this study is to be aware of the real-world data of the current breast cancer diagnosis and treatment model in the county. It aims to understand the gap between the county and the SOC in the diagnosis and treatment.

NCT ID: NCT05544110 Recruiting - PTSD Clinical Trials

Precise Transcranial Magnetic Stimulation for Post-traumatic Stress Disorder

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of repetitive transcranial magnetic stimulation under precise localization for post-traumatic stress disorder

NCT ID: NCT05544071 Recruiting - Clinical trials for Major Depressive Disorder

the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia

Start date: February 12, 2023
Phase: N/A
Study type: Interventional

This study evaluates a schedule of precise repetitive transcranial magnetic stimulation for depressive adolescent with anhedonia. In this randomized controlled trial, half of the participants will receive repetitive transcranial magnetic stimulation, and the other will receive sham stimulation.

NCT ID: NCT05544045 Terminated - Clinical trials for Aneurysm, Intracranial

China Surpass Streamline Post-Market Study

Start date: June 3, 2022
Phase:
Study type: Observational

A multi-center, prospective, single-arm, non-randomized, post-market, observational study. The primary objective of this study is to evaluate the long-term safety and efficacy of the Surpass Streamline Flow Diverter System (FDS) in the treatment of unruptured large and giant (≥ 10 mm) saccular wide-neck (neck width ≥ 4 mm) or fusiform intracranial aneurysms in the internal carotid artery from the petrous segment to the terminus arising from a parent vessel with a diameter ≥ 2.5 mm to ≤ 5.3 mm.

NCT ID: NCT05543967 Recruiting - Clinical trials for Type 2 Diabetes Mellitus

Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive Impairment

Start date: October 18, 2022
Phase:
Study type: Observational

This is a cross-sectional and longitudinal study to establish diagnostic models based on olfactory function assessments and odor-induced brain activation for cognitive impairment in patients with type 2 diabetes mellitus.